Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Purple Biotech Ltd. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 15 | 13 | −2 |
| Shares | 580.4K | 762.7K | +182.3K (+31.4%) |
| Value | $2.40M | $3.72M | +$1.32M (+55.3%) |
New holders (4)
Institutions that held Purple Biotech Ltd. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 525,000 | $2.56M | 0.01% |
| Condor Capital Management | 21,000 | $102.0K | 0.01% |
| Advisory Services Network, LLC | 1,945 | $9.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (6)
Institutions that held Purple Biotech Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Renaissance Technologies LLC | 219,035 | $905.0K |
| Virtu Financial LLC | 21,658 | $89.0K |
| Simplex Trading, LLC | 5,735 | $23.0K |
| Bank of America Corp | 636 | $2.00K |
| Tradewinds Capital Management, LLC | 550 | $2.00K |
| Meridian Wealth Partners, LLC | 295 | $1.00K |